Based on our results showing that CM-272 had an antiproliferative effect on NSCLC cells and altered the cell cycle, and that some epigenetic drugs can act as cancer drug sensitizers [10, 27] we wondered whether G9a/DNMT1 blockade would synergize with other cancer drugs. Here, DNMT1 is linked to cancer.